Decoy Therapeutics (DCOY) EPS (Basic) (2015 - 2026)
Decoy Therapeutics (DCOY) posted quarterly EPS (Basic) of -$4.18 for Q1 2026, up 97.74% year-over-year from -$2.11 in Q1 2025, and up 95.51% quarter-over-quarter from -$93.17 in Q4 2025.
Decoy Therapeutics (DCOY) EPS (Basic) (2015 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported EPS (Basic) for 12 consecutive years, with -$4.18 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 97.74% year-over-year to -$4.18; the TTM figure through Mar 2026 stood at -$24.67 (up 95.98% YoY), while the FY2025 annual figure was -$129.1, up 87.62% from the prior year.
- EPS (Basic) climbed to -$4.18 in Q1 2026 per DCOY's latest filing, from -$93.17 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$4.18 in Q1 2026 and bottomed at -$13234.3 in Q4 2022.
- Historically, EPS (Basic) has averaged -$2300.6 across 5 years, with a median of -$440.14 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) sank 266.87% — and 2026, when it surged 97.74%.
- Decoy Therapeutics' EPS (Basic) stood at -$13234.3 in 2022, then jumped by 96.74% to -$431.7 in 2023, then soared by 35.56% to -$278.21 in 2024, then soared by 66.51% to -$93.17 in 2025, then soared by 95.51% to -$4.18 in 2026.
- Business Quant data shows DCOY's EPS (Basic) at -$4.18 in Q1 2026, -$93.17 in Q4 2025, and -$22.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | -4.89 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.93 |
| Mar 31, 2026 | -4.18 |
| Dec 31, 2025 | -93.17 |
| Sep 30, 2025 | -22.30 |
| Jun 30, 2025 | -82.01 |
| Mar 31, 2025 | -184.93 |
| Dec 31, 2024 | -278.21 |
| Sep 30, 2024 | -142.34 |
| Jun 30, 2024 | -440.14 |
| Mar 31, 2024 | -609.56 |
| Dec 31, 2023 | -431.70 |
| Sep 30, 2023 | -971.30 |
| Jun 30, 2023 | -2,111.32 |
| Mar 31, 2023 | -3,263.49 |
| Dec 31, 2022 | -13,234.33 |
| Sep 30, 2022 | -9,281.27 |
| Jun 30, 2022 | -3,199.71 |
| Mar 31, 2022 | -4,760.49 |
| Dec 31, 2021 | -3,607.36 |
| Sep 30, 2021 | -3,227.47 |